KAPRON Tablet

Tranexamic Acid

500 mg

AMOUN PHARMACEUTICAL CO.S.A.E.

Pack size	20's Pack
Dispensing mode
Source
Agent
Retail Price	1.17 AED

Indications

KAPRON Tablet is used for: Haemorrhage, Hereditary angioedema

Adult Dose

Oral Short-term management of haemorrhage Adult: 1-1.5 g or 15-25 mg/kg bid or tid. Management of hereditary angioedema Adult: 1-1.5 g bid or tid. Intravenous Short-term management of haemorrhage Adult: 0.5-1 g or 10 mg/kg tid or 25-50 mg/kg daily by continuous infusion.

Child Dose

Oral Short-term management of haemorrhage Child: 25 mg/kg bid or tid. Management of hereditary angioedema Child: 25 mg/kg bid or tid. Intravenous Short-term management of haemorrhage Child: 10 mg/kg bid or tid.

Renal Dose

Renal impairment: Adjust dose based on serum creatinine concentration: 120-250 micromol/l: 15 mg/kg bid daily; 250-500 micromol/l: 15 mg/kg once daily; >500 micromol/l: 7.5 mg/kg once daily or 15 mg/kg once every 48 hr.

Administration

May be taken with or without food.

Contra Indications

Severe renal failure, active intravascular clotting, thromboembolic disease, colour vision disorders, subarachnoid bleeding.

Precautions

Mild to moderate renal impairment, irregular menstrual bleeding, previous history of thromboembolic disease, haematuria. Monitor closely in disseminated intravascular coagulation. Monitor LFT and eye examination regularly during long-term use. Discontinue if disturbance in colour vision occurs. Avoid IV inj rate >1 ml/minute due to risk of hypotension. Pregnancy, lactation.

Pregnancy-Lactation

Pregnancy Category: B Lactation: Excreted in breast milk, not recommended

Interactions

Potentially Fatal: Increased risk of thrombus formation with estrogens, Factor IX complex concentrates or anti-inhibitor coagulant concentrates. Increased risk of fatal thrombotic complications with tretinoin in acute promyelocytic leukaemia.

Adverse Effects

Side effects of Tranexamic Acid : >10% Headache (50.4%), Nasal and sinus symptoms (25.4%), Back pain (20.7%), Abdominal pain (19.8%), Musculoskeletal pain (11.2%) 1-10% Arthralgia (6.9%), Muscle cramps and spasms (5.8%), Migraine (6%), Anemia (5.6%), Fatigue (5.2%) Frequency Not Defined Visual abnormalities, Hypotension (with rapid injection), Nausea, Vomiting, Diarrhea

Mechanism of Action

Tranexamic acid is an antifibrinolytic agent that competitively inhibits breakdown of fibrin clots. It blocks binding of plasminogen and plasmin to fibrin, thereby preventing haemostatic plug dissolution.

Note

KAPRON 500 mg Tablet manufactured by AMOUN PHARMACEUTICAL CO.S.A.E.. Its generic name is Tranexamic Acid. KAPRON is availble in Saudi Arabia. Farmaco SA drug index information on KAPRON Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Tranexamic Acid :

Solution for Injection

CYKLOKAPRON ^{100 mg/ml}

ALCON-COUVREUR n.v.

Solution for Injection

Dr. GERHARD MANN CHEM.- PHARM.FABRIK GmbH

Solution for Injection

TRAPRON ^{100 mg/ml}

PT. Novell Pharmaceutical Laboratories

Solution for Injection

Tranexamic acid BOS ^{100 mg/ml}

Gland Pharma Limited